[{"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-001", "question": "A 58-year-old man with a history of hypertrophic cardiomyopathy presents with recurrent syncope. Genetic testing reveals a mutation in the MYH7 gene. Echocardiography shows asymmetric septal hypertrophy with a left ventricular outflow tract gradient of 80 mmHg at rest. Despite optimal medical therapy with beta-blockers, he continues to experience symptoms. What is the most appropriate next step in management?", "options": ["Implantable cardioverter-defibrillator placement", "Septal myectomy", "Alcohol septal ablation", "Dual-chamber pacing", "Mavacamten initiation"], "answer": "E", "answer_index": 4, "explanation": "Mavacamten is the most appropriate next step as it is a cardiac myosin inhibitor specifically indicated for symptomatic obstructive hypertrophic cardiomyopathy refractory to beta-blockers, targeting the underlying pathophysiology. Septal myectomy and alcohol septal ablation are invasive options reserved for cases not responding to medical therapy, but mavacamten offers a non-invasive alternative with recent evidence supporting its use before procedural interventions. Implantable cardioverter-defibrillator and dual-chamber pacing address arrhythmic risks but not the outflow obstruction directly.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To determine the most appropriate next step for this patient with hypertrophic cardiomyopathy (HCM), I'll analyze the key clinical features and treatment options.\n\nThe patient has:\n- Recurrent syncope despite optimal medical therapy (beta-blockers)\n- Confirmed MYH7 gene mutation (common in HCM)\n- Severe outflow tract obstruction (gradient 80 mmHg at rest)\n- Asymmetric septal hypertrophy\n\nFor symptomatic obstructive HCM with significant outflow tract gradient (>50 mmHg) that remains symptomatic despite optimal medical therapy, septal reduction therapy is indicated.\n\nThe two main septal reduction options are:\n- Septal myectomy: Surgical removal of part of the thickened septum\n- Alcohol septal ablation: Catheter-based procedure\n\nSeptal myectomy is generally considered the gold standard treatment for patients with severe symptomatic obstructive HCM refractory to medical therapy, especially in younger patients who can tolerate surgery.\n\nWhile an ICD might address arrhythmic risk, it doesn't treat the outflow obstruction causing symptoms.\nDual-chamber pacing has limited efficacy for severe obstruction.\nMavacamten is a newer medication for obstructive HCM but would be considered before invasive options.\n\nThe answer is (B)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-002", "question": "A 72-year-old woman with Parkinson's disease develops sudden onset of severe headache, vomiting, and left-sided hemiparesis. MRI reveals a right thalamic hemorrhage with intraventricular extension. She is on carbidopa-levodopa and has a history of orthostatic hypotension. What is the most likely underlying mechanism contributing to this event?", "options": ["Cerebral amyloid angiopathy", "Hypertensive vasculopathy", "Levodopa-induced vasospasm", "Orthostatic hypotension-related watershed infarction", "Dopaminergic therapy-associated coagulopathy"], "answer": "B", "answer_index": 1, "explanation": "Hypertensive vasculopathy is the most likely mechanism, as chronic hypertension in elderly patients with Parkinson's often leads to small vessel disease and thalamic hemorrhages. Cerebral amyloid angiopathy typically affects cortical regions, not deep structures like the thalamus. Levodopa does not directly cause vasospasm or coagulopathy, and while orthostatic hypotension is common, it more often results in ischemic rather than hemorrhagic events.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To determine the most likely mechanism for this patient's thalamic hemorrhage, I'll analyze the key clinical features and risk factors.\n\nThe patient presents with:\n- 72-year-old woman with Parkinson's disease\n- Sudden severe headache, vomiting, and left hemiparesis\n- Right thalamic hemorrhage with intraventricular extension\n- On carbidopa-levodopa therapy\n- History of orthostatic hypotension\n\nThalamic hemorrhages are commonly associated with hypertensive vasculopathy, especially in older adults. The basal ganglia and thalamus are supplied by small perforating arteries (lenticulostriate arteries) that are particularly vulnerable to hypertensive damage.\n\nWhile the patient has orthostatic hypotension, this would typically cause ischemic events rather than hemorrhage. Cerebral amyloid angiopathy typically causes lobar hemorrhages rather than deep hemorrhages like this thalamic bleed. There's no established association between levodopa and vasospasm, nor is there evidence for dopaminergic therapy causing coagulopathy that would lead to hemorrhage.\n\nHypertensive vasculopathy remains the most common cause of thalamic hemorrhages, even in patients with Parkinson's disease. The location of the hemorrhage (thalamus with intraventricular extension) is classic for hypertensive bleeds.\n\nThe answer is (B)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-003", "question": "A 45-year-old man with type 1 diabetes mellitus presents with recurrent hypoglycemia despite dose adjustments. He has a history of autoimmune thyroiditis and vitiligo. Laboratory evaluation shows low morning cortisol and elevated ACTH. What is the most appropriate confirmatory test for the suspected diagnosis?", "options": ["Cosyntropin stimulation test", "Insulin tolerance test", "21-Hydroxylase antibody assay", "Adrenal CT scan", "Metyrapone test"], "answer": "C", "answer_index": 2, "explanation": "21-Hydroxylase antibody assay is the most appropriate confirmatory test for autoimmune adrenalitis in the context of polyglandular autoimmune syndrome type 2, given the patient's other autoimmune conditions. Cosyntropin stimulation test assesses adrenal reserve but does not confirm etiology. Insulin tolerance and metyrapone tests evaluate the hypothalamic-pituitary-adrenal axis but are less specific for autoimmune causes, and adrenal CT is imaging that may show atrophy but not confirm autoimmunity.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the most appropriate confirmatory test for this patient, I need to analyze the clinical presentation.\n\nThe patient has:\n- Type 1 diabetes mellitus\n- Recurrent hypoglycemia despite dose adjustments\n- History of autoimmune thyroiditis and vitiligo\n- Low morning cortisol\n- Elevated ACTH\n\nThis clinical picture strongly suggests primary adrenal insufficiency (Addison's disease), likely autoimmune in nature (autoimmune adrenalitis). The combination of multiple autoimmune conditions (type 1 diabetes, thyroiditis, vitiligo) points to autoimmune polyglandular syndrome. The low cortisol with elevated ACTH indicates primary adrenal failure.\n\nFor confirming adrenal insufficiency, the cosyntropin stimulation test is the standard diagnostic test. It evaluates the adrenal glands' ability to respond to ACTH by measuring cortisol levels before and after synthetic ACTH administration.\n\nThe 21-hydroxylase antibody assay would help determine if the cause is autoimmune, but it's not the first confirmatory test for adrenal insufficiency itself.\n\nThe insulin tolerance test is more invasive and risky, especially in a patient with diabetes and hypoglycemia.\n\nAdrenal CT scan would be useful to rule out other causes like hemorrhage or metastases, but isn't the first-line confirmatory test.\n\nThe metyrapone test is less commonly used and more complex than the cosyntropin test.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-004", "question": "A 60-year-old smoker with COPD presents with progressive dyspnea and hemoptysis. CT chest reveals a 2 cm spiculated nodule in the right upper lobe with mediastinal lymphadenopathy. Bronchoscopy with biopsy confirms squamous cell carcinoma. PET-CT shows no distant metastases. What is the most appropriate initial management?", "options": ["Stereotactic body radiotherapy", "Surgical lobectomy with lymph node dissection", "Concurrent chemoradiotherapy", "Immune checkpoint inhibitor monotherapy", "Epidermal growth factor receptor tyrosine kinase inhibitor"], "answer": "B", "answer_index": 1, "explanation": "Surgical lobectomy with lymph node dissection is the most appropriate for stage I squamous cell lung cancer in a patient with adequate pulmonary reserve, offering the best chance for cure. Stereotactic body radiotherapy is an alternative for non-surgical candidates, but this patient has no contraindications mentioned. Chemoradiotherapy and targeted therapies are for more advanced stages or specific molecular profiles not indicated here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To determine the most appropriate initial management for this patient, I need to consider the clinical presentation, diagnosis, and staging information provided.\n\nKey information:\n- 60-year-old smoker with COPD\n- Squamous cell carcinoma confirmed by biopsy\n- 2 cm spiculated nodule in right upper lobe\n- Mediastinal lymphadenopathy present\n- PET-CT shows no distant metastases\n\nThe presence of mediastinal lymphadenopathy suggests N2 disease, which would classify this as Stage IIIA non-small cell lung cancer (assuming the lymph nodes are positive for malignancy). For Stage IIIA NSCLC with mediastinal lymph node involvement, concurrent chemoradiotherapy is typically the standard of care as initial treatment.\n\nSurgical lobectomy would be preferred for earlier stages (I or II) without mediastinal involvement.\n\nStereotactic body radiotherapy is typically used for early-stage disease in patients who cannot tolerate surgery.\n\nImmune checkpoint inhibitors are generally used in advanced disease or as consolidation therapy after chemoradiation.\n\nEGFR tyrosine kinase inhibitors are primarily used for adenocarcinomas with EGFR mutations, not squamous cell carcinomas.\n\nThe answer is (C)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-005", "question": "A 35-year-old woman in the emergency department presents with chest pain, palpitations, and diaphoresis after using cocaine. ECG shows ST-segment elevation in leads V2-V4. Troponin is elevated. Coronary angiography reveals a thrombus in the left anterior descending artery with no underlying atherosclerosis. What is the most appropriate immediate management?", "options": ["Intracoronary thrombolysis", "Percutaneous coronary intervention with stenting", "Systemic anticoagulation with heparin", "Glycoprotein IIb/IIIa inhibitor infusion", "Aspiration thrombectomy"], "answer": "E", "answer_index": 4, "explanation": "Aspiration thrombectomy is the most appropriate for cocaine-induced myocardial infarction due to vasospasm and thrombus without atherosclerosis, allowing removal of the clot while minimizing vessel trauma. Stenting is unnecessary without plaque, and thrombolysis carries bleeding risks. Anticoagulation and glycoprotein inhibitors are adjunctive but not primary interventions for isolated thrombus.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "E", "model_outputs": "To address this case of cocaine-induced myocardial infarction with a thrombus in the LAD artery:\n\nThis patient has cocaine-induced acute coronary syndrome with ST-elevation MI (STEMI) and a documented thrombus in the LAD artery without underlying atherosclerosis. The management approach needs to address both the thrombus and avoid unnecessary stenting in the absence of atherosclerotic disease.\n\nAspiration thrombectomy (E) would be the most appropriate immediate management. This approach allows for direct removal of the thrombus without placing a permanent stent in a coronary artery that doesn't have underlying atherosclerotic disease. Cocaine-induced coronary thrombosis often occurs due to vasospasm and hypercoagulability rather than plaque rupture.\n\nStenting (B) would be inappropriate without underlying atherosclerosis. Systemic anticoagulation (C) or GP IIb/IIIa inhibitors (D) alone would be insufficient for an acute STEMI with a visible thrombus. Intracoronary thrombolysis (A) carries higher bleeding risks compared to mechanical thrombectomy in this setting.\n\nThe answer is (E)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-006", "question": "A 68-year-old man with atrial fibrillation on anticoagulation develops acute right-sided weakness. CT head shows no hemorrhage, and MRI confirms acute ischemic stroke in the left middle cerebral artery territory. He is within 4.5 hours of symptom onset. What is the most critical factor determining eligibility for intravenous thrombolysis?", "options": ["International normalized ratio value", "Time since last anticoagulant dose", "Presence of atrial fibrillation", "Stroke severity on NIHSS scale", "Reversal agent availability"], "answer": "A", "answer_index": 0, "explanation": "The international normalized ratio value is the most critical, as thrombolysis is contraindicated if INR >1.7 in patients on vitamin K antagonists to avoid hemorrhagic complications. Time since last dose affects coagulopathy but INR directly measures it. Atrial fibrillation and stroke severity influence overall management but not thrombolysis eligibility directly, and reversal agents are for bleeding, not pre-thrombolysis.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine eligibility for intravenous thrombolysis in this patient with acute ischemic stroke who is on anticoagulation, I need to consider the key contraindications.\n\nFor patients on anticoagulation therapy (like this patient with atrial fibrillation), the International Normalized Ratio (INR) is the most critical factor determining eligibility for IV thrombolysis (tPA). This is because an elevated INR increases bleeding risk significantly.\n\nCurrent guidelines typically consider:\n- INR â‰¤1.7 as the cutoff for tPA eligibility\n- Patients with higher INR values are generally excluded due to hemorrhage risk\n\nWhile other factors are important:\n- Time since last dose matters but is secondary to the actual INR value\n- Atrial fibrillation itself is not a contraindication\n- NIHSS severity affects benefit assessment but not eligibility\n- Reversal agent availability is not a primary consideration for tPA eligibility\n\nThe INR directly measures the anticoagulation effect, which is the key safety concern.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-007", "question": "A 52-year-old woman with acromegaly undergoes transsphenoidal surgery. Postoperatively, she develops polyuria with urine output exceeding 300 mL/hour. Serum sodium is 148 mEq/L, and urine specific gravity is 1.002. What is the most appropriate initial pharmacologic intervention?", "options": ["Desmopressin acetate", "Hydrochlorothiazide", "Demeclocycline", "Tolvaptan", "Conivaptan"], "answer": "A", "answer_index": 0, "explanation": "Desmopressin acetate is the most appropriate for central diabetes insipidus following pituitary surgery, replacing deficient antidiuretic hormone to concentrate urine. Hydrochlorothiazide is used for nephrogenic diabetes insipidus, not central. Demeclocycline and vasopressin antagonists like tolvaptan or conivaptan are for syndrome of inappropriate antidiuretic hormone, which would worsen hypernatremia here.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To address this clinical scenario, I need to analyze the patient's presentation.\n\nThe patient is a 52-year-old woman who has:\n- Recent transsphenoidal surgery for acromegaly\n- Polyuria (>300 mL/hour)\n- Hypernatremia (serum sodium 148 mEq/L)\n- Very dilute urine (specific gravity 1.002)\n\nThis presentation is consistent with central diabetes insipidus (DI), which is a common complication after pituitary surgery. Central DI occurs due to insufficient antidiuretic hormone (ADH, also called vasopressin) production, leading to inability to concentrate urine, excessive free water loss, and resulting hypernatremia.\n\nThe most appropriate initial treatment for central DI is replacement of the deficient hormone with a synthetic analog:\n\nA. Desmopressin acetate (DDAVP) - This is a synthetic analog of ADH that would directly address the underlying hormone deficiency.\n\nB. Hydrochlorothiazide - Used for nephrogenic DI, not first-line for central DI.\n\nC. Demeclocycline - This actually antagonizes ADH and would worsen the condition.\n\nD. Tolvaptan - This is a vasopressin receptor antagonist that would worsen the condition.\n\nE. Conivaptan - Another vasopressin receptor antagonist that would worsen the condition.\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-008", "question": "A 55-year-old man with idiopathic pulmonary fibrosis presents with acute worsening dyspnea. High-resolution CT shows new ground-glass opacities superimposed on fibrosis. Bronchoalveolar lavage reveals neutrophilia without infection. What is the most appropriate therapeutic approach?", "options": ["High-dose systemic corticosteroids", "Azathioprine addition to regimen", "Pirfenidone dose escalation", "Nintedanib initiation", "Lung transplantation evaluation"], "answer": "A", "answer_index": 0, "explanation": "High-dose systemic corticosteroids are the most appropriate for acute exacerbation of idiopathic pulmonary fibrosis, aiming to suppress inflammation despite limited evidence. Azathioprine is contraindicated due to increased mortality risk. Pirfenidone and nintedanib are antifibrotics for stable disease, not acute flares, and transplantation is for end-stage but not immediate management.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To answer this question, I need to identify what clinical scenario is being described and determine the appropriate management.\n\nThe patient has:\n- Idiopathic pulmonary fibrosis (IPF) as baseline condition\n- Acute worsening of dyspnea\n- New ground-glass opacities on HRCT superimposed on fibrosis\n- Neutrophilia on BAL without evidence of infection\n\nThis clinical picture is consistent with an acute exacerbation of IPF, which is characterized by:\n- Acute worsening of respiratory symptoms\n- New radiographic opacities (typically ground-glass)\n- Exclusion of alternative causes (infection, heart failure, etc.)\n- Often shows neutrophilia on BAL\n\nFor acute exacerbations of IPF:\n- High-dose systemic corticosteroids are the standard first-line treatment\n- Azathioprine is not recommended and may be harmful in IPF\n- Pirfenidone and nintedanib are antifibrotic medications for chronic management but not for acute exacerbations\n- While lung transplantation is the definitive treatment for end-stage IPF, it's not the immediate management for an acute exacerbation\n\nThe answer is (A)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-009", "question": "A 28-year-old man in the emergency department after a motor vehicle collision has hypotension, tachycardia, and abdominal distension. FAST exam shows free fluid in the abdomen. He is taken to the operating room for exploratory laparotomy, revealing a splenic laceration. What is the most appropriate intraoperative management for a hemodynamically unstable patient?", "options": ["Splenic artery embolization", "Partial splenectomy", "Splenorrhaphy with hemostatic agents", "Total splenectomy", "Non-operative management with observation"], "answer": "D", "answer_index": 3, "explanation": "Total splenectomy is the most appropriate for hemodynamically unstable patients with high-grade splenic injury to rapidly control bleeding and stabilize the patient. Embolization and non-operative management are for stable patients. Partial splenectomy or splenorrhaphy preserve splenic function but are time-consuming and risky in instability.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "For a hemodynamically unstable patient with a splenic laceration discovered during exploratory laparotomy after trauma, the most appropriate intraoperative management would be total splenectomy.\n\nIn this scenario, the patient is already showing signs of significant blood loss (hypotension, tachycardia, abdominal distension, free fluid on FAST exam) and is described as hemodynamically unstable. When a patient is unstable in this setting, controlling hemorrhage quickly is the priority.\n\nWhile splenic preservation techniques (options B and C) are preferred when possible, they are typically reserved for hemodynamically stable patients or those with less severe injuries. Splenic artery embolization (option A) is an angiographic procedure, not an intraoperative technique. Non-operative management (option E) is contraindicated in unstable patients.\n\nTotal splenectomy provides the most rapid and definitive control of hemorrhage in an unstable patient with a splenic injury discovered during laparotomy.\n\nThe answer is (D)"}, {"quiz_id": "20251201T041413890Z_grok-4-0709_seed123", "question_id": "20251201T041413890Z_grok-4-0709_seed123-010", "question": "A 65-year-old woman with rheumatoid arthritis develops shortness of breath. Echocardiography reveals severe mitral regurgitation with a flail leaflet. She has preserved left ventricular function but elevated pulmonary pressures. Coronary angiography is normal. What is the most appropriate intervention?", "options": ["Mitral valve repair", "Mitral valve replacement with bioprosthesis", "Transcatheter edge-to-edge repair", "Medical management with afterload reduction", "Cardiac resynchronization therapy"], "answer": "A", "answer_index": 0, "explanation": "Mitral valve repair is the most appropriate for severe primary mitral regurgitation due to flail leaflet in a surgical candidate, offering better durability and preservation of ventricular function compared to replacement. Transcatheter repair is for high-risk patients or functional regurgitation. Medical management and resynchronization do not address the structural defect.", "generator_model": "grok-4-0709", "seed": 123, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the most appropriate intervention for this patient, I'll analyze the key clinical information:\n\n- 65-year-old woman with rheumatoid arthritis\n- Severe mitral regurgitation with a flail leaflet\n- Preserved left ventricular function\n- Elevated pulmonary pressures\n- Normal coronary angiography\n\nThe presence of a flail leaflet indicates structural damage to the mitral valve, which is causing severe regurgitation. This is a mechanical problem that typically requires intervention rather than medical management alone.\n\nFor severe mitral regurgitation with a flail leaflet:\n- Mitral valve repair is generally preferred over replacement when feasible\n- Repair preserves the native valve apparatus, which maintains left ventricular geometry and function\n- Repair is associated with better long-term outcomes compared to replacement\n- The patient has preserved LV function, making her an excellent candidate for repair\n\nMitral valve replacement would be considered if repair is not technically feasible. Transcatheter edge-to-edge repair is typically reserved for patients at high surgical risk. Medical management alone is insufficient for severe MR with a flail leaflet. Cardiac resynchronization therapy addresses ventricular dyssynchrony, which is not indicated here.\n\nThe answer is (A)"}]